MAMDC2
MAM domain-containing protein 2
Also known as: MAMC2_HUMAN, MGC21981
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z304
- Gene
- MAMDC2
- Ensembl
- ENSG00000165072
- Chromosome
- 9
- Canonical length
- 686 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Nuclear speckles,Plasma membrane
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to enable glycosaminoglycan binding activity. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>Q7Z304|MAMDC2
1 MLLRGVLLAL QALQLAGALD LPAGSCAFEE STCGFDSVLA SLPWILNEEG HYIYVDTSFG
61 KQGEKAVLLS PDLQAEEWSC LRLVYQITTS SESLSDPSQL NLYMRFEDES FDRLLWSAKE
121 PSDSWLIASL DLQNSSKKFK ILIEGVLGQG NTASIALFEI KMTTGYCIEC DFEENHLCGF
181 VNRWNPNVNW FVGGGSIRNV HSILPQDHTF KSELGHYMYV DSVYVKHFQE VAQLISPLTT
241 APMAGCLSFY YQIQQGNDNV FSLYTRDVAG LYEEIWKADR PGNAAWNLAE VEFSAPYPME
301 VIFEVAFNGP KGGYVALDDI SFSPVHCQNQ TELLFSAVEA SCNFEQDLCN FYQDKEGPGW
361 TRVKVKPNMY RAGDHTTGLG YYLLANTKFT SQPGYIGRLY GPSLPGNLQY CLRFHYAIYG
421 FLKMSDTLAV YIFEENHVVQ EKIWSVLESP RGVWMQAEIT FKKPMPTKVV FMSLCKSFWD
481 CGLVALDDIT IQLGSCSSSE KLPPPPGECT FEQDECTFTQ EKRNRSSWHR RRGETPTSYT
541 GPKGDHTTGV GYYMYIEASH MVYGQKARLL SRPLRGVSGK HCLTFFYHMY GGGTGLLSVY
601 LKKEEDSEES LLWRRRGEQS ISWLRALIEY SCERQHQIIF EAIRGVSIRS DIAIDDVKFQ
661 AGPCGEMEDT TQQSSGYSED LNEIEYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAMDC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 72 nTPM
- fallopian tube: 61 nTPM
- ovary: 49 nTPM
- colon: 46 nTPM
- lung: 38 nTPM
- cervix: 36 nTPM
Single-cell type
- leydig cells: 154 nCPM
- smooth muscle cells: 142 nCPM
- fibroblasts: 132 nCPM
- peritubular myoid cells: 130 nCPM
- macrophages: 117 nCPM
- epicardial cells: 116 nCPM
Immune cell
- NK-cell: 0.6 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 6 nTPM
- thalamus: 4.8 nTPM
- cerebral cortex: 4.3 nTPM
- hypothalamus: 4.2 nTPM
- midbrain: 3.6 nTPM
- white matter: 3.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.28
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAMDC2 as an antibody target. Whether an autoantibody or antibody against MAMDC2 could matter depends on whether native MAMDC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAMDC2 is annotated as secreted, so native MAMDC2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MAMDC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...